Moreover, it was concluded that the serous carcinoma subgroup was characterized by a high AR expression in half of the investigated cases and a subset of serous carcinomas and carcinosarcomas showed some AR staining appearance with a simultaneous lack of ER staining, suggesting the possibility of the application of antiandrogen therapy in these cases [20]. This evidence concerns the gene ESR1 and serous adenocarcinoma.